×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
DIA Clinical Safety and Pharmacovigilance Community Round Table Discussion: Risk Management: Artificial Intelligence - A Disruptive Journey for Pharmacovigilance
Session Chair(s)
Catherine Baldridge, MSc
Head of Safety
Fusion Pharmaceuticals, United States
Seating is limited
Join DIA CSP Community round table discussion tied to session # 382 Artificial Intelligence: A Disruptive Journey for Pharmacovigilance (Wednesday, June 27th)
To include special guest from the session: Glenn Carroll.
Have an account?